Kaskela Law LLC Announces Shareholder Investigation of Inari Medical, Inc. (NASDAQ: NARI) and Encourages Long-Term NARI Shareholders to Contact the Firm

PHILADELPHIA, Sept. 19, 2024 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating Inari Medical, Inc. (NASDAQ: NARI) on behalf of the company’s long-term shareholders. https://kaskelalaw.com/cases/inari-medical/ Recently a securities fraud complaint was filed against Inari Medical on behalf of investors who purchased shares of the company’s stock between February 24, 2022 and February […]

Kaskela Law LLC Announces Shareholder Investigation of Globe Life Inc. (NYSE: GL) and Encourages Long-Term GL Shareholders to Contact the Firm

PHILADELPHIA, Sept. 19, 2024 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating Globe Life Inc. (NYSE: GL), formerly known as Torchmark Corp., on behalf of the company’s long-term shareholders. https://kaskelalaw.com/case/globe-life/ Recently a securities fraud complaint was filed against Globe Life on behalf of investors who purchased shares of the company’s stock between

Kaskela Law LLC Announces Shareholder Investigation of Doximity, Inc. (NYSE: DOCS) and Encourages Long-Term DOCS Shareholders to Contact the Firm

PHILADELPHIA, Sept. 19, 2024 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating Doximity, Inc. (NYSE: DOCS) on behalf of the company’s long-term shareholders. Recently a securities fraud complaint was filed against Doximity on behalf of investors who purchased shares of the company’s stock between February 9, 2022, and April 1, 2024. According

SINTX Announces Completion of $3.1 Million ATM Equity Public Offering

Salt Lake City, Utah, Sept. 19, 2024 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) a leading innovator in ceramic manufacturing, today announced the successful completion of its previously announced “at-the-market” equity public offering (the “ATM Program”) which provided for the offer and sale, from time to time, of shares of

AIM ImmunoTech Reports Positive Preliminary Data in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer

Preliminary finding of stable disease in two out of three patients at 6 months in the first subject cohort Combination of Ampligen and Imfinzi continues to be generally well-tolerated with no severe adverse events or dose-limiting toxicities OCALA, Fla., Sept. 19, 2024 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM”) today announced positive

IT Nation Introduces New IT Nation Torch Award Program for 2024 Flagship Event

TAMPA, Fla., Sept. 19, 2024 (GLOBE NEWSWIRE) — IT Nation, a global community of peers, thought leaders, and experts dedicated to elevating the IT ecosystem to new heights, has announced its new award program, the IT Nation Torch Awards, which will debut at this year’s IT Nation Connect event taking place from November 6-8, 2024,

Humacyte Announces Allowance of U.S. Patent Covering BioVascular Pancreas (BVP(TM))

– New U.S. patent covers the design and composition of the BVP – – Positive results from ongoing preclinical studies support the potential of the BVP to deliver insulin-producing islets as a potential treatment for type 1 diabetes – DURHAM, N.C., Sept. 19, 2024 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform

Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)

–Participant baseline characteristics in INFRONT-3 suggest a representative study population that enables testing of the effects of latozinemab in frontotemporal dementia with a progranulin gene mutation (FTD-GRN)– –Latozinemab, a novel investigational human monoclonal antibody, is the most advanced PGRN-elevating candidate in development for the treatment of FTD-GRN– SOUTH SAN FRANCISCO, Calif., Sept. 19, 2024 (GLOBE

Condor Receives a Second Feed Gas Allocation for Its LNG Projects in Kazakhstan

CALGARY, Alberta, Sept. 19, 2024 (GLOBE NEWSWIRE) — Condor Energies Inc. (“Condor” or the “Company”) (TSX: CDR), a Canadian based energy transition company is pleased to announce that it has received its second natural gas allocation (“Gas Allocation”) from the Kazakhstan State authority responsible for gas distribution. The Gas Allocation will be used as feed

Red Cat Holdings to Report Fiscal First Quarter 2025 Financial Results and Provide Corporate Update on Monday, September 23, 2024

SAN JUAN, Puerto Rico, Sept. 19, 2024 (GLOBE NEWSWIRE) — Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat” or the “Company”), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, announces that financial results for the fiscal first quarter 2025 (3 months ended July 31, 2024) will be reported

Scroll to Top